Download PDF
Dtsch Med Wochenschr 2016; 141(2): 110-114
DOI: 10.1055/s-0041-110068
Dossier
Myokarditis / Kardiomyopathie
© Georg Thieme Verlag KG Stuttgart · New York

Herzerkrankungen in der Schwangerschaft

Cardiovascular disease in pregnancy
Denise Hilfiker-Kleiner
1   Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover
,
Johann Bauersachs
1   Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover
› Author Affiliations
Further Information

Publication History

Publication Date:
22 January 2016 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Kardiovaskuläre Erkrankungen bei werdenden Müttern sind häufig. Wir fassen kurz den aktuellen Wissensstand zu Schwangerschaften zusammen, die durch präexistente maternale Herzerkrankungen kompliziert werden. Wir erklären, weshalb die Schwangerschaft ein Stressmodel für das kardiovaskuläre System ist und wie sich dies bei präexistenten Kardiomyopathien auswirkt. Ausführlich behandeln wir hypertensive Komplikationen in der Schwangerschaft und die peripartale Kardiomyopathie im Hinblick auf Ätiologie, Risikofaktoren, Pathophysiologie, Diagnose, Behandlungskonzept und Prognose. Zum Schluss legen wir dar, dass kardiovaskuläre Erkrankungen in der Schwangerschaft immer interdisziplinär betrachtet werden sollten, um eine gute Heilung der Mutter und möglichst keine Schädigung des Fötus zu erreichen

Abstract

Cardiovascular diseases are among the most frequent complications in pregnancies. Among them preexisting heart diseases including congenital heart disease, genetic cardiomyopathies, myocardial infarction and chemotherapy-induced cardiomyopathies display a special challenge for the mother and her physicians. Moreover, the incidence of cardiovascular disease induced by or associated with pregnancy, i.e. hypertensive disorders and peripartum cardiomyopathies, has increased over the past decades. In the present overview we explain why pregnancy is a stress model for the maternal heart and summarize the current knowledge on the influence of pregnancy on preexisting cardiomyopathies. We highlight recent advances in research with regard to hypertensive complications in pregnancy and peripartum cardiomyopathy (PPCM). Moreover, we summarize etiologies, risk factors, pathomechanisms, diagnosis, treatment, management and prognosis. Finally, interdisciplinarity between different clinical fields and basic science is a key requirement to avoid longterm damage to the cardiovascular system induced by pregnancy associated impacts and with this improve women‘s health in general.

Schlüsselwörter

Schwangerschaft - Bluthochdruck - Präeklampsie - peripartale Kardiomyopathie - Herzinsuffizienz

Keywords

pregnancy - hypertension - preeclampsia - peripartum cardiomyopathy - heart failure
 

  • Literatur

  • 1 Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 3147-3197
    CrossrefPubMedGoogle Scholar
  • 2 Sliwa K, Hilfiker-Kleiner D, Petrie MC et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010; 12: 767-778
    CrossrefPubMedGoogle Scholar
  • 3 Sliwa K, Johnson MR, Zilla P, Roos-Hesselink JW. Management of valvular disease in pregnancy: a global perspective. Eur Heart J 2015; 36: 1078-1089
    CrossrefPubMedGoogle Scholar
  • 4 Roos-Hesselink JW, Cornette J, Sliwa K, Pieper PG et al. Contraception and cardiovascular disease. Eur Heart J 2015; 36: 1728-1734
    CrossrefPubMedGoogle Scholar
  • 5 Hilfiker-Kleiner D, Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol 2014; 11: 364-370
    CrossrefPubMedGoogle Scholar
  • 6 Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006; 368: 687-693
    CrossrefPubMedGoogle Scholar
  • 7 van Spaendonck-Zwarts KY, van den Posafalvi A, Berg MP et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J 2014; 35: 2165-2173
    CrossrefPubMedGoogle Scholar
  • 8 van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010; 121: 2169-2175
    CrossrefPubMedGoogle Scholar
  • 9 van Tintelen JP, Pieper PG, Van Spaendonck-Zwarts KY, Van Den Berg MP. Pregnancy, cardiomyopathies, and genetics. Cardiovasc Res 2014; 101: 571-578
    CrossrefPubMedGoogle Scholar
  • 10 Morales A, Painter T, Li R et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010; 121: 2176-2182
    CrossrefPubMedGoogle Scholar
  • 11 Selle T, Renger I, Labidi S et al. Reviewing peripartum cardiomyopathy: current state of knowledge. Future Cardiol 2009; 5: 175-189
    CrossrefPubMedGoogle Scholar
  • 12 Hilfiker-Kleiner D. ‘Social freezing’ of women’s eggs. Eur Heart J 2015; 36: 773
    PubMedGoogle Scholar
  • 13 Roos-Hesselink JW, Ruys TP, Stein JI et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J 2013; 34: 657-665
    CrossrefPubMedGoogle Scholar
  • 14 Bello N, Rendon IS, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol 2013; 62: 1715-1723
    CrossrefPubMedGoogle Scholar
  • 15 Rana S, Powe CE, Salahuddin S et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012; 125: 911-919
    CrossrefPubMedGoogle Scholar
  • 16 Ahmed R, Dunford J, Mehran R et al. Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol 2014; 63: 1815-1822
    CrossrefPubMedGoogle Scholar
  • 17 Conrad KP, Davison JM. The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? Am J Physiol Renal Physiol. 2014; 306: F1121-F1135
    PubMedGoogle Scholar
  • 18 Mannisto T, Mendola P, Vaarasmaki M et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation 2013; 127: 681-690
    CrossrefPubMedGoogle Scholar
  • 19 Vikse BE. Pre-eclampsia and the risk of kidney disease. Lancet 2013; 382: 104-106
    CrossrefPubMedGoogle Scholar
  • 20 Williams D. Long-term complications of preeclampsia. Semin Nephrol 2011; 31: 111-122
    CrossrefPubMedGoogle Scholar
  • 21 Haghikia A, Podewski E, Libhaber E et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol 2013; 108: 366
    CrossrefPubMedGoogle Scholar
  • 22 Brar SS, Khan SS, Sandhu GK et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 2007; 100: 302-304
    CrossrefPubMedGoogle Scholar
  • 23 Fett JD. Peripartum cardiomyopathy. Insights from Haiti regarding a disease of unknown etiology. Minn Med 2002; 85: 46-48
    PubMedGoogle Scholar
  • 24 Fett JD, Christie LG, Carraway RD et al. Unrecognized peripartum cardiomyopathy in Haitian women. Int J Gynaecol Obstet 2005; 90: 161-166
    CrossrefPubMedGoogle Scholar
  • 25 Sliwa K, Forster O, Libhaber E et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006; 27: 441-446
    CrossrefPubMedGoogle Scholar
  • 26 Kamiya CA, Kitakaze M, Ishibashi-Ueda H et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J 2011; 75: 1975-1981
    CrossrefPubMedGoogle Scholar
  • 27 Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 2015; 36: 1090-1097
    CrossrefPubMedGoogle Scholar
  • 28 Labidi S, Hilfiker-Kleiner D, Klein G. Left bundle branch block during pregnancy as a sign of imminent peripartum cardiomyopathy. Eur Heart J 2011; 9: 1076
    PubMedGoogle Scholar
  • 29 Hilfiker-Kleiner D, Podewski E, Roentgen P, Bauersachs J. Schwangerschaftsassoziierte Kardiomyopathie. SpringerReference Innere Medizin 2015; DOI: 10.1007/978-3-642-54676-1_183-1
    PubMedGoogle Scholar
  • 30 Hilfiker-Kleiner D, Meyer GP, Schieffer E et al. Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J Am Coll Cardiol 2007; 50: 2354-2355
    CrossrefPubMedGoogle Scholar
  • 31 Hilfiker-Kleiner D, Kaminski K, Podewski E et al. A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy. Cell 2007; 128: 589-600
    CrossrefPubMedGoogle Scholar
  • 32 Patten IS, Rana S, Shahul S et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012; 485: 333-338
    CrossrefPubMedGoogle Scholar
  • 33 Sliwa K, Blauwet L, Tibazarwa K et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010; 121: 1465-1473
    CrossrefPubMedGoogle Scholar
  • 34 Sliwa K, Forster O, Tibazarwa K et al. Long-term outcome of peripartum cardiomyopathy in a population with high seropositivity for human immunodeficiency virus. Int J Cardiol 2011; 147: 202-208
    CrossrefPubMedGoogle Scholar
  • 35 Haghikia A, Röntgen P, Vogel-Claussen J et al. Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study. ESC Heart Failure 2015; 2: 139-149
    CrossrefPubMedGoogle Scholar